Patients seen at transplant centers had almost 80% higher odds to receive “bridge-to-transplant” designation

William Moldwin published a book, won awards and is making more plans for his future.

And the development of a new slow-release drug seeks to target them

Radiation, used to treat half of all cancer patients, can be measured during treatment for the first time with precise 3D imaging developed at the University of Michigan.

More than half of adults surveyed reported that the use of cannabis led them to decrease their pain medications.

Researchers identify new ways to characterize states of consciousness

A new program is finding many diagnosed in childhood with antibiotic allergies are no longer allergic after retesting

A review of maternal deaths suggests most individuals had documented behavioral health conditions but only one-third received appropriate pharmacologic treatment before death

These services, researchers found, were largely inaccessible to people who use sign language, discriminating against already ‘severely marginalized’ population in the United States.

Here’s what topics resonated with most readers of the Michigan Health blog. Can you guess what they were?

The year provided one fascinating research story after another.

Masks are an easy and low-cost way to reduce the amount of virus entering the air and spreading to others.

Nicknamed the “invisible disease”, the autoimmune disorder comes with lifestyle changes that can be a challenging adjustment.

Scientists link dozens of new genome sites to coronary artery disease risk and pioneer a powerful method for illuminating the biological roots of common disease.

In mouse models and serum samples, an FDA-approved drug that lowers ammonia levels made the tumors more sensitive to treatment.